-
InsightsNews - Corporate - POSTED: July 2 2021
Brachers advises UK Medical Limited on acquisition of Neurologic Europe
- Share this article
- Print this article
-
Brachers has advised UK Medical Limited on its acquisition of Neurologic Europe.
UK Medical supplies a range of interventional medical devices to the NHS and private healthcare sector. Established in 1987, the company makes products for the breast radiology, urology, interventional radiology and cardiology markets. Neurologic Europe is a medical device distributor, specialising in innovative technologies for the interventional neuroradiology market.
The acquisition will enhance UK Medical’s offering, adding a new range of innovative medical imaging technologies alongside their current product range.
The team at Brachers have acted for UK Medical for six years and previously advised on the management buyout in 2017. James Bullock, Head of Corporate, and Corporate solicitor Kieron Cummins advised on the current deal.
James said: “This is an exciting time for UK Medical. Having previously advised Ian and the management team on their MBO acquisition of the company , it’s great to see the business grow and expand its product offering through this strategic acquisition. With a shared focus on improving patient experience and clinical outcomes, the acquisition of Neurologic Europe is a great outcome for the healthcare sector and its patients.”
Ian Aaron, Managing Director of UK Medical, said: “We are delighted that Brachers were able to advise us on our recent acquisition of Neurologic Europe. I’d like to thank James and Kieron for their professionalism, strategic advice and commercial acumen, which was key to ensuring a successful deal.”
This content is correct at time of publication
Can we help?
Take a look at our Corporate page for useful information, resources, guidance, details of our team and how we may be able to help you
-
Key contact:
Get in touch
Please fill out the below form or alternatively you can call us on 01622 690691